Search the web
Welcome, Guest
[Sign Out, My Account]
Hoovers

Wednesday, April 1 2015 2:02pm ET - U.S. Markets close in 1 hour and 58 minutes.
Industry Center
Industry Center > > Pharmaceutical Product Development, LLC Company Profile
More On This Industry
· Summary
· News
· Leaders & Laggards
· Company Index
·Industry Browser
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Need more? Get unbiased, in-depth information on public and private companies worldwide.
  
Pharmaceutical Product Development, LLC Company Profile
Pharmaceutical Product Development (PPD) is on the hunt for newfangled drugs. One of the world's largest contract research organizations (CROs), PPD provides global research and development services to pharmaceutical, biotech, and medical device companies seeking regulatory approval for their products. The CRO offers a broad range of services, from toxicology testing in the earliest phases of drug research, to the management of large, multi-site clinical trials in which drug compounds are tested on human subjects. Its customers have included most of the world's top 50 pharma companies.
Headlines for Pharmaceutical Product Development, LLC
Singapore-based Quadria Capital closes landmark Indonesia pharma deal
- Thu Mar 12
Why we're cautious about 2015: Germany's Merck
- Tue Mar 3
Teva to buy U.S. drug developer Auspex Pharma for $3.5 bln
- Mon Mar 30
Teva to buy U.S. drug developer Auspex Pharma for $3.5 billion
- Mon Mar 30
'Indian pharma firms must innovate in face of generic drugs slowdown'
- Mon Mar 16
In swansong, FDA chief defends drug approval process
- Fri Mar 27
Old-economy sectors are now tech, too: US study
- Mon Mar 2
Exclusive: Drug that caused 'elephant man' side effect makes comeback after 2006 disaster
- Tue Mar 24
Old economy sectors are now tech, too
- Thu Mar 5
The Future of Birth Control for Women
- Thu Mar 19
Contact Information
Address: 929 N. Front St.
Wilmington, NC 28401-3331
Phone:910-251-0081
Fax:910-762-5820
Financial Highlights
Fiscal Year End:December
Key People
Chairman and CEO: David Simmons
COO: William J. Sharbaugh
EVP and CFO: Robert Hureau
Industry Information
Sector:
Industry:
Top Competitors
Covance Inc. (cvd)
PAREXEL International Corporation (prxl)
Quintiles Transnational Holdings, Inc. (q)
 


Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2015 Morningstar, Inc. All Rights Reserved. Company information © 2015 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2015, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?